Journal Article Review Epublish 20 citations
PubMed: 38400091 DOI: 10.3390/v16020316
The Influenza A Virus Replication Cycle: A Comprehensive Review.
Viruses 16(2)
Authors: Toby Carter, Munir Iqbal
Affiliations
- The Pirbright Institute, Ash Road, Pirbright, Woking GU24 0NF, UK.
Abstract
Influenza A virus (IAV) is the primary causative agent of influenza, colloquially called the flu. Each year, it infects up to a billion people, resulting in hundreds of thousands of human deaths, and causes devastating avian outbreaks with worldwide losses worth billions of dollars. Always present is the possibility that a highly pathogenic novel subtype capable of direct human-to-human transmission will spill over into humans, causing a pandemic as devastating if not more so than the 1918 influenza pandemic. While antiviral drugs for influenza do exist, they target very few aspects of IAV replication and risk becoming obsolete due to antiviral resistance. Antivirals targeting other areas of IAV replication are needed to overcome this resistance and combat the yearly epidemics, which exact a serious toll worldwide. This review aims to summarise the key steps in the IAV replication cycle, along with highlighting areas of research that need more focus.
MeSH
Virus Replication, Influenza, Human, Antiviral Agents, Virology, Viruses, Influenza A Virus, Pandemics
Cited by
- Molecular cloning and characterization of duck CD83 and its effect on H9N2 avian influenza virus replication. Poult Sci, 2025
- Triethylamine inhibits influenza A virus infection and growth via mechanisms independent of viral neuraminidase and RNA-dependent RNA polymerase. PLoS One, 2025
- Advances and Challenges in Antiviral Development for Respiratory Viruses. Pathogens, 2025
- Multiplex real-time reverse transcription recombinase-aided amplification assay for the detection of SARS-CoV-2, influenza A virus, and respiratory syncytial virus. Microbiol Spectr, 2025
- Bid Protein: A Participant in the Apoptotic Network with Roles in Viral Infections. Int J Mol Sci, 2025
- Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus. Biomolecules, 2025
- Highly Pathogenic Avian Influenza (H5N1) Clade 2.3.4.4b in Cattle: A Rising One Health Concern. Animals (Basel), 2025
- Recombinant Influenza A Viruses Expressing Reporter Genes from the Viral NS Segment. Int J Mol Sci, 2024
- hnRNPH1 Inhibits Influenza Virus Replication by Binding Viral RNA. Microorganisms, 2025
- The Effects of Viral Structural Proteins on Acidic Phospholipids in Host Membranes. Viruses, 2024
- A Strand-Specific Quantitative RT-PCR Method for Detecting vRNA, cRNA, and mRNA of H7N9 Avian Influenza Virus in a Mouse Model. Viruses, 2025
- The Antiviral Activity of Polyphenols. Mol Nutr Food Res, 2025
- Visualizing and analyzing 3D biomolecular structures using Mol* at RCSB.org: Influenza A H5N1 virus proteome case study. Protein Sci, 2025
- Molecular Dynamics Investigation of the Influenza Hemagglutinin Conformational Changes in Acidic pH. J Phys Chem B, 2024
- The peculiar characteristics and advancement in diagnostic methodologies of influenza A virus. Front Microbiol, 2025
- Molecular Mechanisms Underlying Response to Influenza in Grey Seals (Halichoerus grypus), a Potential Wild Reservoir. Mol Ecol, 2025